PUBLIC COMPANY
save$BFRIBiofrontera Inc.
$BFRIWoburn, MA, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
- phase3Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
- phase2Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 5, 26option exerciseLuebbert Hermann · CEO & Chairman137,500 sh
- Mar 5, 26option exerciseLuebbert Hermann · CEO & Chairman137,500 sh
- Mar 5, 26option exerciseLeffler Eugene Frederick · Chief Financial Officer87,500 sh
- Mar 5, 26option exerciseLeffler Eugene Frederick · Chief Financial Officer87,500 sh
- Mar 4, 26grantWeber Kevin Daniel · 20,000 sh
- Mar 4, 26grantLuebbert Hermann · CEO & Chairman125,000 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that